Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CardioVascular Technologies (CVT) is a specialized medical device company and innovation hub focused on the development of surgical and catheter-based technologies for cardiovascular applications. Founded by the prolific medical inventor Dr. Thomas J. Fogarty, the company has established a significant intellectual property portfolio in interventional cardiology and vascular surgery. CVT's business model centers on developing novel device concepts, such as vascular closure systems and advanced stents, and subsequently licensing these technologies to major industry players or spinning them off into independent startups. The company also provides high-level consulting services for rapid prototyping and the design of medical device manufacturing facilities. With a legacy of pioneering work in minimally invasive surgery, CVT continues to be a key contributor to the evolution of cardiovascular care through its extensive patent licensing and technology development programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CardioVascular Technologies.